Results 11 to 20 of about 41,916 (253)

Evaluation of Immunogenicity of Seasonal Influenza Split HA Vaccines Involved With Changes of Vaccine Strains Using Mouse and Human Sera. [PDF]

Microbiol Immunol
ABSTRACT Seasonal influenza is prevalent every winter, and influenza vaccines are used to safeguard public health. As the influenza vaccines are produced in embryonated hen eggs using vaccine viruses recommended by the World Health Organization each year based on the epidemic situation, it is important, from the perspective of public health, to ...
Sato K, Shimasaki N, Fujisaki S, Nishijima H, Kuwahara T, Nakai Y, Murano K, Asanuma H, Watanabe S, Harada Y, Ryo A, Tashiro M, Itamura S.   +12 more
europepmc   +2 more sources

H3N2 Virus Outbreak: A latest global threat

Journal of Zoonotic Diseases, 2023
The current H3N2 virus outbreak has sent shockwaves worldwide, with health officials rushing to stop its spread. This form of influenza has been wreaking havoc around the globe, culminating in an alarming number of hospitalizations and fatalities.
Manisha Vohra , Mohammad Amir , Amit Sharma , Ian Osoro   +3 more
doaj   +2 more sources

Genetic characteristics of influenza A/H3N2 virus in Jiaxing, China (2019–2024) [PDF]

Virology Journal
The rapid evolution of influenza A/H3N2 virus underscores the imperative for ongoing surveillance. In this study, we analyzed 7,872 respiratory samples collected from patients with influenza-like symptoms in Jiaxing, China, between 2019 and 2024 ...
Yin Song, Xue Zhang, Jimei Ji, Lina Li, Yamei Zhou, Ping Li, Ganglin Ren, Shencong Lv, Xiaofei Zhang, Yong Yan, Guoying Zhu   +10 more
doaj   +2 more sources

Structure of an H3N2 influenza virus nucleoprotein [PDF]

Acta Crystallographica Section F Structural Biology Communications, 2021
Influenza A viruses of the H1N1 and H3N2 subtypes are responsible for seasonal epidemic events. The influenza nucleoprotein (NP) binds to the viral genomic RNA and is essential for its replication. Efforts are under way to produce therapeutics and vaccines targeting the NP.
Michael L. Knight, Haitian Fan, David L. V. Bauer, Jonathan M. Grimes, Ervin Fodor, Jeremy R. Keown   +5 more
openaire   +3 more sources

The frequency and outcome of Influenza in children admitted to Tabriz children's training and treatment center in Northwest Iran During 2014-2019 [PDF]

مجله پزشکی دانشگاه علوم پزشکی تبریز, 2023
Background. Influenza causes various seasonal respiratory diseases, resulting in significant morbidity and mortality in children. Influenza is a highly contagious disease causing global pandemics. This study aimed to investigate the frequency and outcome
Babak Abdinia, Azar Dastranji, Ali Akbar Abedini, Iman Moghbel, Golnaz Mobayen   +4 more
doaj   +1 more source

National influenza mid-season report, 2020–2021

Canada Communicable Disease Report, 2021
Canada’s national influenza season typically starts in the latter half of November (week 47) and is defined as the week when at least 5% of influenza tests are positive and a minimum of 15 positive tests are observed.
Liza Lee, Kelly Butt, Steven Buckrell, Andrea Nwosu, Claire Sevenhuysen, Christina Bancej   +5 more
doaj   +1 more source

Vaccine effectiveness estimates from an early-season influenza A(H3N2) epidemic, including unique genetic diversity with reassortment, Canada, 2022/23

Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 2023
The Canadian Sentinel Practitioner Surveillance Network estimated vaccine effectiveness (VE) during the unusually early 2022/23 influenza A(H3N2) epidemic.
D. Skowronski, E. Chuang, S. Sabaiduc, S. Kaweski, S. Kim, James A. Dickinson, R. Olsha, J. Gubbay, N. Zelyas, H. Charest, N. Bastien, A. Jassem, G. De Serres   +12 more
semanticscholar   +1 more source

Evolution of Influenza A(H3N2) Viruses in 2 Consecutive Seasons of Genomic Surveillance, 2021–2023

Open Forum Infectious Diseases, 2023
Background The circulation and the genomic evolution of influenza A(H3N2) viruses during the 2021/2022 and 2022/2023 seasons were studied and associated with infection outcomes.
A. Fall, Lijie Han, Madeline Yunker, Yu-Nong Gong, Tai-Jung Li, J. Norton, O. Abdullah, Richard E. Rothman, Katherine Z. J. Fenstermacher, C. P. Morris, A. Pekosz, Eili Y Klein, H. Mostafa   +12 more
semanticscholar   +1 more source

Bivalent H1 and H3 COBRA Recombinant Hemagglutinin Vaccines Elicit Seroprotective Antibodies against H1N1 and H3N2 Influenza Viruses from 2009 to 2019

Journal of Virology, 2022
Standard-of-care influenza virus vaccines are composed of a mixture of antigens from different influenza viral subtypes. For the first time, lead COBRA H1 and H3 HA antigens, formulated as a bivalent vaccine, have been investigated in animals with ...
James D. Allen, T. Ross
semanticscholar   +1 more source

Influenza Vaccine Effectiveness Against Influenza A(H3N2)-Related Illness in the United States During the 2021-2022 Influenza Season

medRxiv, 2022
Background. In the United States, influenza activity during the 2021-2022 season was modest and sufficient enough to estimate influenza vaccine effectiveness for the first time since the beginning of the COVID-19 pandemic.
A. Price, B. Flannery, K. Talbot, Carlos G. Grijalva, K. Wernli, H. Phillips, A. Monto, E. Martin, E. Belongia, H. McLean, M. Gaglani, M. Mutnal, K. M. Geffel, M. Nowalk, S. Tartof, A. Florea, C. McLean, S. Kim, M. Patel, J. Chung   +19 more
semanticscholar   +1 more source